FDAnews
www.fdanews.com/articles/180721-amend-surgical-nabs-fda-clearance-for-nanofuse-ba

Amend Surgical Nabs FDA Clearance for NanoFUSE BA

March 2, 2017

The company has received marketing clearance for NanoFUSE BA as a bone graft extender for spine and orthopedic applications.

The device has bioactive glass which facilitates operative site graft containment through rapid bone bonding and the subsequent activation of cellular bone formation. — Cynthia Jessup

View today's stories